Niclas is spearheading an initiative to use Open Innovation at the core of drug research with focus on driving innovation with external collaborations at LEO Pharma. Prior to setting up the LEO Pharma Open Innovation platform, Niclas was heading the molecular pharmacology department.
With passion for pushing boundaries and as a strong believer in inter-disciplinary science he is now exploring how to disrupt traditional R&D to promote mutual benefits and more open ways to collaborate across traditional barriers and borders.
Niclas holds two degrees, PhD in medical sciences and MSc in molecular biology, with a focus on and drug discovery. The current role as heading the R&D Open Innovation initiative focuses on strategic development and operational implementation of open innovation to catalyze the use of external research and fuel the drug pipeline, expand disease understanding and boost corporate innovation with opportunities that otherwise wouldn’t happen.
November 13, 2019
The Connected Lab
- The Connected Lab
This stream covers the ways labs connect to facilitate globalised research and specialisation hubs as well as the innovations and technology that automates the lab, connects devices and enables scientists to spend their time on science.
- 2:50 pmDeploying an open innovation platform to drive external innovation